News
-
-
PRESS RELEASE
Leclanché SA: Announces Extension of Publication Deadline for 2024 Interim Results Due to Ongoing Due Diligence with Pinnacle International Capital
Leclanché extends publication deadline for 2024 interim results due to ongoing due diligence with Pinnacle International Capital, approved by SIX Exchange Regulation AG -
-
-
-
PRESS RELEASE
Moderna and Cenra Healthcare Enter Joint Agreement to Promote Moderna’s mRNA Respiratory Vaccine Portfolio in Taiwan, Including COVID-19 Vaccines
Moderna Inc. and Cenra Healthcare enter joint agreement to co-promote mRNA respiratory vaccine portfolio in Taiwan, enhancing public health initiatives. Details undisclosed -
-
PRESS RELEASE
Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and business activities update, including launch of obesity program and licensing agreement with Blanver for Latin America, with a focus on key achievements and financial highlights -
REGULATED PRESS RELEASE
Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
Biophytis publishes first-half financial results and updates on business activities, highlighting key achievements including launch of OBA program for obesity with BIO101 and exclusive licensing agreement with Blanver for Latin America -
PRESS RELEASE
Clean Air Metals Files Interim Financial Statements for the Six Months Ended July 31, 2024
Clean Air Metals Inc. announces unaudited financial results for the six-month period ended July 31, 2024. Total assets $37.6M, cash $4.2M, working capital $923K, equity $33.7M. CEO confident in project development. Exploration company Thunder Bay North project advancing with notable resource potential
